All Stories

  1. Systematic cascade screening in the Danish Fabry Disease Centre: 20 years of a national single-centre experience

    Article • PLoS ONE, November 2022, PLOS

    Professor Ulla Feldt-Rasmussen

  2. Significant hearing loss in Fabry disease: Study of the Danish nationwide cohort prior to treatment

    Article • PLoS ONE, December 2019, PLOS

    Professor Ulla Feldt-Rasmussen

  3. Completeness of RET testing in patients with medullary thyroid carcinoma in Denmark 1997–2013: a nationwide study

    Article • Clinical Epidemiology, January 2019, Dove Medical Press

    Professor Ulla Feldt-Rasmussen

  4. Adrenal insufficiency is seen in more than one-third of patients during ongoing low-dose prednisolone treatment for rheumatoid arthritis

    Article • European Journal of Endocrinology, September 2017, Bioscientifica

    Professor Ulla Feldt-Rasmussen

  5. Corrigendum to “Challenges in Interpretation of Thyroid Function Tests in Pregnant Women with Autoimmune Thyroid Disease”

    Article • Journal of Thyroid Research, January 2017, Hindawi Publishing Corporation

    Sofie Bliddal, Professor Ulla Feldt-Rasmussen

  6. Adrenal Insufficiency Caused by Locally Applied Glucocorticoids-Myth or Fact?

    Article • Current Medicinal Chemistry, August 2015, Bentham Science Publishers

    Professor Ulla Feldt-Rasmussen

  7. Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2015, Endocrine Society

    Professor Ulla Feldt-Rasmussen, Professor Gudmundur Johannsson, Daniel Bengtsson

  8. Early endocrine alterations reflect prolonged stress and relate to 1-year functional outcome in patients with severe brain injury

    Article • March 2015, Bioscientifica

    Professor Ulla Feldt-Rasmussen, Djordje Marina

  9. Quality of Life in Patients with Benign Nontoxic Goiter: Impact of Disease and Treatment Response, and Comparison with the General Population

    Article • Thyroid, March 2015, Mary Ann Liebert Inc

    Professor Ulla Feldt-Rasmussen

  10. Thyroglobulin measurement by highly sensitive assays: focus on laboratory challenges

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2015, De Gruyter

    Professor Ulla Feldt-Rasmussen, MD Ph.D. Luca LG Giovanella

  11. Thyroid-specific questions on work ability showed known-groups validity among Danes with thyroid diseases

    Article • Quality of Life Research, December 2014, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  12. Ophthalmic experience over 10 years in an observational nationwide Danish cohort of Fabry patients with access to enzyme replacement

    Article • Acta Ophthalmologica, December 2014, Wiley

    Professor Ulla Feldt-Rasmussen, MD Christoffer Valdorff Madsen

  13. Claus Brun (1914-2014)

    Article • Nephrology Dialysis Transplantation, November 2014, Oxford University Press (OUP)

    Professor Ulla Feldt-Rasmussen

  14. Primary Hyperparathyroidism in Young People. When Should We Perform Genetic Testing for Multiple Endocrine Neoplasia 1 (MEN-1)?

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2014, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  15. Exploring the Experiences of People With Hypo- and Hyperthyroidism

    Article • Qualitative Health Research, October 2014, SAGE Publications

    Professor Ulla Feldt-Rasmussen

  16. Corrigendum to “Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself” [Eur J Intern Med, 24 (8), 714–720]

    Article • European Journal of Internal Medicine, October 2014, Elsevier

    Professor Ulla Feldt-Rasmussen

  17. The Thyroid-Related Quality of Life Measure ThyPRO Has Good Responsiveness and Ability to Detect Relevant Treatment Effects

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2014, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  18. OR7-1: A reversible albumin-binding GH derivative possesses a promising once-weekly treatment profile and is well tolerated in adult subjects with growth hormone deficiency

    Article • Growth Hormone & IGF Research, October 2014, Elsevier

    Professor Ulla Feldt-Rasmussen

  19. PO2-11: Evidence for truncated somatostatin receptor 5 modulation of therapy response to somatostatin analogues in two patients with acromegaly and severe headache

    Article • Growth Hormone & IGF Research, October 2014, Elsevier

    Professor Ulla Feldt-Rasmussen

  20. Confirmatory factor analysis of the thyroid-related quality of life questionnaire ThyPRO

    Article • Health and Quality of Life Outcomes, September 2014, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  21. Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO

    Article • Quality of Life Research, September 2014, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  22. Increased Risk of Long-Term Sickness Absence, Lower Rate of Return to Work, and Higher Risk of Unemployment and Disability Pensioning for Thyroid Patients: A Danish Register-Based Cohort Study

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2014, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  23. Thyroglobulin Autoantibodies as Surrogate Biomarkers in the Management of Patients with Differentiated Thyroid Carcinoma

    Article • Current Medicinal Chemistry, August 2014, Bentham Science Publishers

    Professor Ulla Feldt-Rasmussen

  24. Effects of Long-term Growth Hormone Replacement in Adults With Growth Hormone Deficiency Following Cure of Acromegaly: A KIMS Analysis

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2014, Endocrine Society

    Professor Ulla Feldt-Rasmussen, Professor Gudmundur Johannsson, Marta Korbonits

  25. Incidence and late prognosis of acromegaly in Denmark: preliminary data

    Article • April 2014

    Professor Ulla Feldt-Rasmussen

  26. Prolactin hyperproduction does not predict the risk of glucose metabolic disturbances in patients with acromegaly

    Article • April 2014

    Professor Ulla Feldt-Rasmussen

  27. Glucocorticoid-induced adrenal insufficiency in prednisolone treated patients and how it relates to glucocorticoid dose and the duration of treatment

    Article • April 2014

    Professor Ulla Feldt-Rasmussen

  28. Di-ethylhexyl-phthalate is metabolised by human thyroid cells and may influence thyroglobulin secretion

    Article • April 2014

    Professor Ulla Feldt-Rasmussen

  29. Evidence for truncated somatostatin receptor 5 modulation of therapy response to somatostatin analogues in two patients with acromegaly and severe headache

    Article • April 2014

    Professor Ulla Feldt-Rasmussen

  30. DIAGNOSIS OF ENDOCRINE DISEASE: Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper

    Article • April 2014, Bioscientifica

    Professor Ulla Feldt-Rasmussen, MD Ph.D. Luca LG Giovanella

  31. The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial

    Article • Trials, April 2014, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  32. Sleep-wake and melatonin pattern in craniopharyngioma patients

    Article • March 2014, Bioscientifica

    Professor Ulla Feldt-Rasmussen, chief physician Poul Jennum

  33. Development and implementation of PROgmatic: A clinical trial management system for pragmatic multi-centre trials, optimised for electronic data capture and patient-reported outcomes

    Article • Clinical Trials, February 2014, SAGE Publications

    Professor Ulla Feldt-Rasmussen

  34. Female Fabry disease: significant improvement of Fabry disease-related gastrointestinal symptoms in a large cohort of female patients treated with agalsidase beta: data from the Fabry Registry

    Article • Molecular Genetics and Metabolism, February 2014, Elsevier

    Professor Ulla Feldt-Rasmussen

  35. Myxoedema coma: an almost forgotten, yet still existing cause of multiorgan failure

    Article • BMJ Case Reports, January 2014, BMJ

    Professor Ulla Feldt-Rasmussen

  36. Anxiety and Depression Are More Prevalent in Patients with Graves' Disease than in Patients with Nodular Goitre

    Article • European Thyroid Journal, January 2014, Bioscientifica

    Professor Ulla Feldt-Rasmussen

  37. Prevalence of Posttraumatic Growth Hormone Deficiency Is Highly Dependent on the Diagnostic Set-up: Results From The Danish National Study on Posttraumatic Hypopituitarism

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2014, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  38. Faculty of 1000 evaluation for Anatabine supplementation decreases thyroglobulin antibodies in patients with chronic lymphocytic autoimmune (Hashimoto's) thyroiditis: A randomized controlled clinical trial.

    Article • December 2013, F1000Research

    Professor Ulla Feldt-Rasmussen

  39. Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself

    Article • European Journal of Internal Medicine, December 2013, Elsevier

    Professor Ulla Feldt-Rasmussen

  40. Gestational age-specific reference ranges from different laboratories misclassify pregnant women's thyroid status: comparison of two longitudinal prospective cohort studies

    Article • November 2013, Bioscientifica

    Professor Ulla Feldt-Rasmussen, Sofie Bliddal

  41. Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease

    Article • Nephrology Dialysis Transplantation, November 2013, Oxford University Press (OUP)

    Professor Ulla Feldt-Rasmussen

  42. Faculty of 1000 evaluation for A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes.

    Article • October 2013, F1000Research

    Professor Ulla Feldt-Rasmussen

  43. Faculty of 1000 evaluation for Effectiveness of an oxidized cellulose patch hemostatic agent in thyroid surgery: a prospective, randomized, controlled study.

    Article • October 2013, F1000Research

    Professor Ulla Feldt-Rasmussen

  44. Faculty of 1000 evaluation for Neural correlates of free T3 alteration after catecholamine depletion in subjects with remitted major depressive disorder and in controls.

    Article • October 2013, F1000Research

    Professor Ulla Feldt-Rasmussen

  45. Faculty of 1000 evaluation for Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysis.

    Article • October 2013, F1000Research

    Professor Ulla Feldt-Rasmussen

  46. Massive prolactinoma in women: a study of 15 cases

    Article • October 2013, Bioscientifica

    Etienne Delgrange, Professor Ulla Feldt-Rasmussen, Professor Gerald Raverot

  47. Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position Statement

    Article • Thyroid, October 2013, Mary Ann Liebert Inc

    Professor Ulla Feldt-Rasmussen

  48. Central Hypothyroidism and Its Replacement Have a Significant Influence on Cardiovascular Risk Factors in Adult Hypopituitary Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2013, Endocrine Society

    Professor Ulla Feldt-Rasmussen, Djordje Marina

  49. Faculty of 1000 evaluation for Interventions for clinical and subclinical hypothyroidism pre-pregnancy and during pregnancy.

    Article • August 2013, F1000Research

    Professor Ulla Feldt-Rasmussen

  50. Faculty of 1000 evaluation for Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma.

    Article • August 2013, F1000Research

    Professor Ulla Feldt-Rasmussen

  51. Faculty of 1000 evaluation for Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma.

    Article • August 2013, F1000Research

    Professor Ulla Feldt-Rasmussen

  52. Few items in the thyroid-related quality of life instrument ThyPRO exhibited differential item functioning

    Article • Quality of Life Research, June 2013, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  53. Circulating levels of pegvisomant and endogenous growth hormone during prolonged pegvisomant therapy in patients with acromegaly

    Article • Clinical Endocrinology, June 2013, Wiley

    Professor Ulla Feldt-Rasmussen

  54. Differential item functioning of the thyroid-specific quality of life questionnaire ThyPRO

    Article • March 2013

    Professor Ulla Feldt-Rasmussen

  55. Hypopituitarism after fractionated stereotactic radiation therapy of anterior skull base meningiomas is caused by mass effects, not radiation

    Article • March 2013

    Professor Ulla Feldt-Rasmussen

  56. Relationship between early endocrine alterations and functional outcome in patients with severe brain injury

    Article • March 2013

    Professor Ulla Feldt-Rasmussen

  57. The characterization of sleep--wake pattern and its association with melatonin, as a marker of the circadian function of the suprachiasmatic nucleus, in craniopharyngioma patients

    Article • March 2013

    Professor Ulla Feldt-Rasmussen, chief physician Poul Jennum

  58. The prevalence of insufficient test responses in patients with traumatic brain injury compared to healthy controls -- results from The Danish National Study on posttraumatic hypopituitarism

    Article • March 2013

    Professor Ulla Feldt-Rasmussen

  59. Response to GH treatment in adult GH deficiency is predicted by gender, age, and IGF1 SDS but not by stimulated GH-peak

    Article • February 2013, Bioscientifica

    Professor Ulla Feldt-Rasmussen

  60. Careful Assessment of Maternal Thyroid Function Can Prevent Cases of Fetal Goitrous Hypothyroidism

    Article • Fetal Diagnosis and Therapy, January 2013, Karger Publishers

    Professor Ulla Feldt-Rasmussen, Sofie Bliddal

  61. Selenium supplementation for patients with Graves� hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial

    Article • Trials, January 2013, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  62. Results and summary of voting among the audience during presentation and discussion of Medullary Thyroid Carcinoma clinical guidelines prepared by American Thyroid Association

    Article • Thyroid Research, January 2013, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  63. Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease

    Article • Thyroid Research, January 2013, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  64. Acute presentation of craniopharyngioma in children and adults in a Danish national cohort

    Article • Pituitary, December 2012, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  65. Further Thoughts on the Diagnosis and Diagnostic Criteria for Thyroid Storm

    Article • Thyroid, November 2012, Mary Ann Liebert Inc

    Professor Ulla Feldt-Rasmussen

  66. P01-50 Smoking, body composition and bone health in adult patients with Growth Hormone (GH)-treated GH deficiency – an observational study

    Article • Growth Hormone & IGF Research, October 2012, Elsevier

    Professor Ulla Feldt-Rasmussen

  67. P03-39 Cross-sectional studies are prone to selection bias; example from the Danish national study on posttraumatic hypopituitarism

    Article • Growth Hormone & IGF Research, October 2012, Elsevier

    Professor Ulla Feldt-Rasmussen

  68. Fabry disease in children: agalsidase‐beta enzyme replacement therapy

    Article • Clinical Genetics, September 2012, Wiley

    Professor Ulla Feldt-Rasmussen

  69. Mannose 6-Phosphate Receptor and Sortilin Mediated Endocytosis of α-Galactosidase A in Kidney Endothelial Cells

    Article • PLoS ONE, June 2012, PLOS

    Professor Ulla Feldt-Rasmussen

  70. Thyroid effects of endocrine disrupting chemicals

    Article • Molecular and Cellular Endocrinology, May 2012, Elsevier

    Professor Ulla Feldt-Rasmussen

  71. Similar Clinical Features Among Patients with Severe Adult Growth Hormone Deficiency Diagnosed with Insulin Tolerance Test or Arginine or Glucagon Stimulation Tests

    Article • Endocrine Practice, May 2012, AACE Corp (American Association of Clinical Endocrinologists)

    Professor Ulla Feldt-Rasmussen

  72. Endocrinology

    Article • Clinical Therapeutics, April 2012, Elsevier

    Professor Ulla Feldt-Rasmussen

  73. P20—Agalsidase Beta Treatment is Associated With Improvement in Quality of Life in Patients With Fabry Disease: Findings From the Fabry Registry

    Article • Clinical Therapeutics, April 2012, Elsevier

    Professor Ulla Feldt-Rasmussen

  74. P27—Uptake of α-Galactosidase a in Human Glomerular Podocytes is Mediated by Various Receptors in Fabry Disease

    Article • Clinical Therapeutics, April 2012, Elsevier

    Professor Ulla Feldt-Rasmussen

  75. Overall and cause-specific mortality in GH-deficient adults on GH replacement

    Article • March 2012, Bioscientifica

    Professor Ulla Feldt-Rasmussen

  76. Thyroid cancer in Denmark 1943–2008, before and after iodine supplementation

    Article • International Journal of Cancer, March 2012, Wiley

    Professor Ulla Feldt-Rasmussen

  77. The Case of Hypopituitarism in Traumatic Brain Injury

    Article • March 2012, IntechOpen

    Professor Ulla Feldt-Rasmussen

  78. Anti-α-galactosidase A antibody response to agalsidase beta treatment: Data from the Fabry Registry

    Article • Molecular Genetics and Metabolism, March 2012, Elsevier

    Professor Ulla Feldt-Rasmussen

  79. Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood

    Article • January 2012, Bioscientifica

    Professor Ulla Feldt-Rasmussen, Oskar Ragnarsson, Professor Gudmundur Johannsson

  80. Neuroendocrine Monitoring

    Article • January 2012, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  81. Neuroendocrine Treatment

    Article • January 2012, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  82. Is Thyroid Autoimmunity per se a Determinant of Quality of Life in Patients with Autoimmune Hypothyroidism?

    Article • European Thyroid Journal, January 2012, Bioscientifica

    Professor Ulla Feldt-Rasmussen

  83. Recommendations on Reintroduction of Agalsidase Beta for Patients with Fabry Disease in Europe, Following a Period of Shortage

    Article • JIMD Reports, January 2012, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen, Professor franco cecchi, Dr Bojan Vujkovac

  84. Endocrine disorders in pregnancy: Physiological and hormonal aspects of pregnancy

    Article • Best Practice & Research Clinical Endocrinology & Metabolism, December 2011, Elsevier

    Professor Ulla Feldt-Rasmussen

  85. Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association

    Article • November 2011, Bioscientifica

    Professor Ulla Feldt-Rasmussen

  86. Diagnostic dilemma: A young woman with Fabry disease symptoms, no family history, and a “sequencing cryptic” α-galactosidase a large deletion

    Article • Molecular Genetics and Metabolism, November 2011, Elsevier

    Professor Ulla Feldt-Rasmussen

  87. The metabolic consequences of thyroxine replacement in adult hypopituitary patients

    Article • Pituitary, October 2011, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen, Professor Gudmundur Johannsson

  88. Receptor-Mediated Endocytosis of α-Galactosidase A in Human Podocytes in Fabry Disease

    Article • PLoS ONE, September 2011, PLOS

    Moin Saleem, Professor Ulla Feldt-Rasmussen

  89. The Benefits of Invasive Treatment of Fetal Goitrous Hypothyroidism in Maternal Graves' Disease

    Article • Thyroid, August 2011, Mary Ann Liebert Inc

    Professor Ulla Feldt-Rasmussen, Sofie Bliddal

  90. Escitalopram and Neuroendocrine Response in Healthy First-Degree Relatives to Depressed Patients – A Randomized Placebo-Controlled Trial

    Article • PLoS ONE, June 2011, PLOS

    Professor Ulla Feldt-Rasmussen

  91. Faculty Opinions recommendation of Selenium and the course of mild Graves' orbitopathy.

    Article • June 2011, F1000Research

    Professor Ulla Feldt-Rasmussen

  92. Interleukin-8 production from human somatotroph adenoma cells is stimulated by interleukin-1β and inhibited by growth hormone releasing hormone and somatostatin

    Article • Growth Hormone & IGF Research, June 2011, Elsevier

    Professor Ulla Feldt-Rasmussen

  93. Comment on “intrauterine diagnosis and management of fetal goiter: A case report”

    Article • Journal of Clinical Ultrasound, April 2011, Wiley

    Professor Ulla Feldt-Rasmussen, Sofie Bliddal

  94. Antithyroid drug induced fetal goiter

    Article • Nature Reviews Endocrinology, March 2011, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen, Sofie Bliddal

  95. Pegylated Long-Acting Human Growth Hormone Possesses a Promising Once-Weekly Treatment Profile, and Multiple Dosing Is Well Tolerated in Adult Patients with Growth Hormone Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2011, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  96. Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults

    Article • Journal of Neuro-Oncology, February 2011, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  97. Graves' Disease in Pregnancies Complicated by Fetal Goitrous Hypothyroidism in Utero T4 treatment

    Article • Thyroid, January 2011, Mary Ann Liebert Inc

    Professor Ulla Feldt-Rasmussen, Sofie Bliddal

  98. Lessons Learned from 15 Years of KIMS and 5 Years of ACROSTUDY

    Article • Hormone Research in Paediatrics, January 2011, Karger Publishers

    Professor Ulla Feldt-Rasmussen

  99. Challenges in Interpretation of Thyroid Function Tests in Pregnant Women with Autoimmune Thyroid Disease

    Article • Journal of Thyroid Research, January 2011, Wiley

    Professor Ulla Feldt-Rasmussen, Sofie Bliddal

  100. Do Thyroid Disrupting Chemicals Influence Foetal Development during Pregnancy?

    Article • Journal of Thyroid Research, January 2011, Hindawi Publishing Corporation

    Professor Ulla Feldt-Rasmussen, Sofie Bliddal

  101. Fabry Disease and Early Stroke

    Article • Stroke Research and Treatment, January 2011, Hindawi Publishing Corporation

    Professor Ulla Feldt-Rasmussen

  102. Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: Findings from the Fabry Registry

    Article • Genetics in Medicine, November 2010, Elsevier

    Professor Ulla Feldt-Rasmussen

  103. GH and IGF1 levels are positively associated with musculotendinous collagen expression: experiments in acromegalic and GH deficiency patients

    Article • September 2010

    Professor Ulla Feldt-Rasmussen

  104. Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease?

    Article • Nutrition & Metabolism, September 2010, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  105. Childhood Exposure to Phthalates: Associations with Thyroid Function, Insulin-like Growth Factor I, and Growth

    Article • Environmental Health Perspectives, July 2010, Environmental Health Perspectives

    Professor Ulla Feldt-Rasmussen

  106. Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women

    Article • European Journal of Heart Failure, June 2010, Wiley

    Professor Ulla Feldt-Rasmussen

  107. Autoimmunity in differentiated thyroid cancer: Significance and related clinical problems

    Article • HORMONES, April 2010, Hellenic Endocrine Society

    Professor Ulla Feldt-Rasmussen

  108. Fractionated stereotactic radiotherapy in patients with acromegaly: an interim single-centre audit

    Article • February 2010

    Professor Ulla Feldt-Rasmussen

  109. Clinical features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing's disease

    Article • January 2010

    Professor Ulla Feldt-Rasmussen

  110. Hypopituitarism is uncommon after aneurysmal subarachnoid haemorrhage

    Article • Clinical Endocrinology, January 2010, Wiley

    Professor Ulla Feldt-Rasmussen

  111. P18 Baseline characteristics and quality of life in patients with childhood-onset growth hormone deficiency due to Cushing's disease and non-functioning pituitary adenoma

    Article • Growth Hormone & IGF Research, January 2010, Elsevier

    Professor Ulla Feldt-Rasmussen

  112. OR7,39 GH responsiveness in hypopituitary patients with very severe adult GHD using insulin, arginine or glucagon stimulation tests is associated with IGF-I SDS but not with the stimulated GH peak

    Article • Growth Hormone & IGF Research, January 2010, Elsevier

    Professor Ulla Feldt-Rasmussen

  113. Faculty Opinions recommendation of Autoimmune thyroid disease in children and adolescents with idiopathic pulmonary arterial hypertension.

    Article • December 2009, F1000Research

    Professor Ulla Feldt-Rasmussen

  114. Cardiovascular and Cerebrovascular Events in Temporal Relationship to Intravenous Glucocorticoid Pulse Therapy in Patients with Severe Endocrine Ophthalmopathy

    Article • Thyroid, December 2009, Mary Ann Liebert Inc

    Professor Ulla Feldt-Rasmussen

  115. Environmental chemicals and thyroid function: an update

    Article • Current Opinion in Endocrinology Diabetes and Obesity, October 2009, Wolters Kluwer Health

    Professor Ulla Feldt-Rasmussen

  116. Association of Thyroid Gland Volume, Serum Insulin-Like Growth Factor-I, and Anthropometric Variables in Euthyroid Prepubertal Children

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2009, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  117. Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO

    Article • October 2009

    Professor Ulla Feldt-Rasmussen

  118. Narrow intra-individual variation of maternal thyroid function in pregnancy based on a longitudinal study on 132 women

    Article • September 2009

    Professor Ulla Feldt-Rasmussen

  119. Radioiodine treatment for non-toxic goitre

    Article • F1000 Medicine Reports, September 2009, F1000Research

    Professor Ulla Feldt-Rasmussen

  120. Functional and structural nerve fiber findings in heterozygote patients with Fabry disease

    Article • Pain, September 2009, Wolters Kluwer Health

    Professor Ulla Feldt-Rasmussen

  121. Autonomic skin responses in females with Fabry disease

    Article • Journal of the Peripheral Nervous System, September 2009, Wiley

    Professor Ulla Feldt-Rasmussen

  122. From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysis

    Article • August 2009

    Professor Ulla Feldt-Rasmussen

  123. Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram vers...

    Article • Trials, August 2009, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen, Professor Olaf B Paulson

  124. P1.10 Autonomic control of heart rate and blood pressure in Anderson–Fabry's disease

    Article • Autonomic Neuroscience, August 2009, Elsevier

    Professor Ulla Feldt-Rasmussen

  125. Hypothyroidism is associated with signs of endothelial dysfunction despite 1‐year replacement therapy with levothyroxine

    Article • Clinical Endocrinology, May 2009, Wiley

    Professor Ulla Feldt-Rasmussen

  126. Is increase in bone mineral content caused by increase in skeletal muscle mass/strength in adult patients with GH-treated GH deficiency? A systematic literature analysis

    Article • May 2009

    Professor Ulla Feldt-Rasmussen

  127. Establishing construct validity for the thyroid-specific patient reported outcome measure (ThyPRO): an initial examination

    Article • Quality of Life Research, March 2009, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  128. Iodine and tri-iodo-thyronine reduce the incidence of type 1 diabetes mellitus in the autoimmune prone BB rats

    Article • Autoimmunity, January 2009, Taylor & Francis

    Professor Ulla Feldt-Rasmussen

  129. Faculty Opinions recommendation of Serum concentrations of adiponectin in patients with hyperthyroidism before and after control of thyroid function.

    Article • September 2008, F1000Research

    Professor Ulla Feldt-Rasmussen

  130. Elevated third-trimester haemoglobin A1c predicts preterm delivery in type 1 diabetes

    Article • Journal of Diabetes and its Complications, September 2008, Elsevier

    Professor Ulla Feldt-Rasmussen

  131. P-20 Growth hormone treatment in patients on hemodialysis is associated with an increase in serum mannose-binding lectin levels

    Article • Growth Hormone & IGF Research, September 2008, Elsevier

    Professor Ulla Feldt-Rasmussen

  132. GH replacement in hypopituitarism improves lipid profile and quality of life independently of changes in obesity variables

    Article • August 2008

    Professor Ulla Feldt-Rasmussen

  133. Reduced Parietooccipital White Matter Glutamine Measured by Proton Magnetic Resonance Spectroscopy in Treated Graves’ Disease Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2008, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  134. Improving a newly developed patient-reported outcome for thyroid patients, using cognitive interviewing

    Article • Quality of Life Research, July 2008, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  135. Thyroid Autoantibodies and Thyroid Function in Subjects Exposed to Chernobyl Fallout during Childhood: Evidence for a Transient Radiation-Induced Elevation of Serum Thyroid Antibodies without an Increase in Thyroid Autoimmune Disease

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2008, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  136. Improving a newly developed patient-reported outcome for thyroid patients, using cognitive interviewing

    Article • Quality of Life Research, June 2008, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  137. Faculty Opinions recommendation of Papillary carcinoma of the thyroid gland in a child of thyrotoxicosis patient receiving radioactive iodine therapy: report of a case.

    Article • April 2008, F1000Research

    Professor Ulla Feldt-Rasmussen

  138. Faculty Opinions recommendation of Endocrine disruptors and the thyroid gland--a combined in vitro and in vivo analysis of potential new biomarkers.

    Article • April 2008, F1000Research

    Professor Ulla Feldt-Rasmussen

  139. Does the type and severity of brain injury predict hypothalamo–pituitary dysfunction? Does post-traumatic hypopituitarism predict worse outcome?

    Article • Pituitary, April 2008, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  140. Morbidity and GH deficiency: a nationwide study.

    Article • March 2008

    Claus H. Gravholt, Professor Ulla Feldt-Rasmussen

  141. Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry

    Article • Molecular Genetics and Metabolism, February 2008, Elsevier

    Professor Ulla Feldt-Rasmussen, prof alberto ortiz

  142. Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density

    Article • Genetics in Medicine, December 2007, Elsevier

    Professor Ulla Feldt-Rasmussen

  143. Immunohistochemical staining for thyroid peroxidase (TPO) of needle core biopsies in the diagnosis of scintigraphically cold thyroid nodules

    Article • Clinical Endocrinology, November 2007, Wiley

    Professor Ulla Feldt-Rasmussen

  144. Interactions Between Growth Hormone and the Thyroid Gland - with Special Reference to Biochemical Diagnosis

    Article • Current Medicinal Chemistry, November 2007, Bentham Science Publishers

    Professor Ulla Feldt-Rasmussen

  145. Posttraumatic Hypopituitarism Is Associated with an Unfavorable Body Composition and Lipid Profile, and Decreased Quality of Life 12 Months after Injury

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2007, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  146. Faculty Opinions recommendation of Thyroid autoimmunity and thyroid dysfunction in women with endometriosis.

    Article • September 2007, F1000Research

    Professor Ulla Feldt-Rasmussen

  147. Signs of maternal vascular dysfunction precede preeclampsia in women with type 1 diabetes

    Article • Journal of Diabetes and its Complications, September 2007, Elsevier

    Professor Ulla Feldt-Rasmussen

  148. Prevalence and predictive factors of post-traumatic hypopituitarism

    Article • Clinical Endocrinology, August 2007, Wiley

    Professor Ulla Feldt-Rasmussen

  149. Mortality and GH deficiency: a nationwide study

    Article • July 2007

    Claus H. Gravholt, Professor Ulla Feldt-Rasmussen

  150. Treatment of Hypothyroidism in Elderly Patients and in Patients with Cardiac Disease

    Article • Thyroid, July 2007, Mary Ann Liebert Inc

    Professor Ulla Feldt-Rasmussen

  151. Which Domains of Thyroid-Related Quality of Life Are Most Relevant? Patients and Clinicians Provide Complementary Perspectives

    Article • Thyroid, July 2007, Mary Ann Liebert Inc

    Professor Ulla Feldt-Rasmussen

  152. Clinical Implications of Residual Growth Hormone (GH) Response to Provocative Testing in Adults with Severe GH Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2007, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  153. 285 ABNORMALITIES IN SMALL FIBRE STRUCTURE AND FUNCTION IN FEMALE FABRY PATIENTS

    Article • European Journal of Pain, June 2007, Wiley

    Professor Ulla Feldt-Rasmussen

  154. Faculty Opinions recommendation of Thiazolidinedione induced thyroid associated orbitopathy.

    Article • May 2007, F1000Research

    Professor Ulla Feldt-Rasmussen

  155. Acute and long‐term pituitary insufficiency in traumatic brain injury: a prospective single‐centre study

    Article • Clinical Endocrinology, May 2007, Wiley

    Professor Ulla Feldt-Rasmussen

  156. Faculty Opinions recommendation of Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis.

    Article • May 2007, F1000Research

    Professor Ulla Feldt-Rasmussen

  157. Thyroid and Leptin

    Article • Thyroid, May 2007, Mary Ann Liebert Inc

    Professor Ulla Feldt-Rasmussen

  158. Factors Influencing the Adrenocorticotropin Test: Role of Contemporary Cortisol Assays, Body Composition, and Oral Contraceptive Agents

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2007, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  159. Faculty Opinions recommendation of Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery.

    Article • March 2007, F1000Research

    Professor Ulla Feldt-Rasmussen

  160. Distribution of α-Galactosidase A in Normal Human Kidney and Renal Accumulation and Distribution of Recombinant α-Galactosidase A in Fabry Mice

    Article • Journal of the American Society of Nephrology, March 2007, Wolters Kluwer Health

    Professor Ulla Feldt-Rasmussen

  161. Metabolic Effects of Growth Hormone

    Article • January 2007, Karger Publishers

    Professor Ulla Feldt-Rasmussen

  162. Affective symptoms and cognitive functions in the acute phase of Graves’ thyrotoxicosis

    Article • Psychoneuroendocrinology, January 2007, Elsevier

    Professor Ulla Feldt-Rasmussen

  163. Diversity of neuropathy in a familywith Fabry disease

    Article • Clinical Therapeutics, January 2007, Elsevier

    Professor Ulla Feldt-Rasmussen

  164. P-62 CHANGES IN LIPID PROFILE IN ADULTS WITH GROWTH HORMONE DEFICIENCY (GHD) AFTER 1 YEAR OF GH REPLACEMENT THERAPY: CORRELATION WITH PARAMETERS OF OBESITY

    Article • Growth Hormone & IGF Research, November 2006, Elsevier

    Professor Ulla Feldt-Rasmussen

  165. P-63 RELATIONSHIP BETWEEN GH RESPONSES TO SEVERAL STIMULATION TESTS AND VARIABLES OF LIPID METABOLISM AND BODY COMPOSITION IN ADULT PATIENTS WITH SEVERE GH DEFICIENCY- INSIGHT FROM THE KIMS DATABASE

    Article • Growth Hormone & IGF Research, November 2006, Elsevier

    Professor Ulla Feldt-Rasmussen

  166. Is there a need to optimize glycemic control in hemodialyzed diabetic patients?

    Article • Kidney International, October 2006, Elsevier

    Professor Ulla Feldt-Rasmussen

  167. What is the optimal follow-up strategy for patients with papillary thyroid microcarcinoma?

    Article • Nature Clinical Practice Endocrinology &#38 Metabolism, August 2006, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  168. P3–095: High frequencies of thyroid disease in mixed memory clinic patients

    Article • Alzheimer s & Dementia, July 2006, Wiley

    Professor Ulla Feldt-Rasmussen

  169. P1–141: Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis

    Article • Alzheimer s & Dementia, July 2006, Wiley

    Professor Ulla Feldt-Rasmussen

  170. Small‐fibre neuropathy in female Fabry patients: reduced allodynia and skin blood flow after topical capsaicin

    Article • Journal of the Peripheral Nervous System, June 2006, Wiley

    Professor Ulla Feldt-Rasmussen

  171. Characteristics of the Danish families with multiple endocrine neoplasia type 1

    Article • Molecular and Cellular Endocrinology, April 2006, Elsevier

    Professor Ulla Feldt-Rasmussen

  172. Serum levels of activin A and inhibin A are not related to the increased susceptibility to pre‐eclampsia in type I diabetic pregnancies

    Article • Acta Obstetricia Et Gynecologica Scandinavica, February 2006, Wiley

    Professor Ulla Feldt-Rasmussen

  173. Growth Hormone Replacement Therapy in Adults: Responsiveness Related to Life Quality

    Article • January 2006, Elsevier

    Professor Ulla Feldt-Rasmussen

  174. Effect on Muscles of Long-Term Treatment with Growth Hormone (GH) in Adults with GH Deficiency: KIMS Data and Review of the Literature

    Article • Hormone Research in Paediatrics, January 2006, Karger Publishers

    Professor Ulla Feldt-Rasmussen

  175. Pegvisomant Treatment in a 4-Year-Old Girl with Neurofibromatosis Type 1

    Article • Hormone Research in Paediatrics, January 2006, Karger Publishers

    Professor Ulla Feldt-Rasmussen

  176. Estrogen Replacement in Women of Fertile Years with Hypopituitarism

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2005, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  177. Cotreatment of Acromegaly with a Somatostatin Analog and a Growth Hormone Receptor Antagonist

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2005, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  178. Isolated growth hormone (GH) deficiency in adult patients: Baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database

    Article • Growth Hormone & IGF Research, October 2005, Elsevier

    Professor Ulla Feldt-Rasmussen

  179. Adrenocortical insufficiency after pituitary surgery: an audit of the reliability of the conventional short synacthen test

    Article • Clinical Endocrinology, September 2005, Wiley

    Professor Ulla Feldt-Rasmussen

  180. Estimation of number of follicles, volume of colloid and inner follicular surface area in the thyroid gland of rats

    Article • Journal of Anatomy, July 2005, Wiley

    Professor Ulla Feldt-Rasmussen

  181. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I

    Article • May 2005

    Claus H. Gravholt, Professor Ulla Feldt-Rasmussen

  182. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD

    Article • Clinical Endocrinology, January 2005, Wiley

    Professor Ulla Feldt-Rasmussen

  183. Combined Dietary and Pharmacological Weight Management in Obese Hypopituitary Patients

    Article • Obesity Research, November 2004, Wiley

    Professor Ulla Feldt-Rasmussen

  184. Impaired health-related quality of life in Graves' disease. A prospective study

    Article • November 2004

    Professor Ulla Feldt-Rasmussen

  185. Neonatal stimulation of the thyroid gland with iodine or suppression during adolescence with triiodothyronine changes the prevalence of autoimmune thyroiditis in BB rats

    Article • September 2004

    Professor Ulla Feldt-Rasmussen

  186. Unsuccessful Radioiodine Treatment of a Non-Toxic Goiter: A Case Report

    Article • Pharmacology & Toxicology, August 2004, Wiley

    Professor Ulla Feldt-Rasmussen

  187. Abnormal bone collagen morphology and decreased bone strength in growth hormone-deficient rats

    Article • Bone, July 2004, Elsevier

    Professor Ulla Feldt-Rasmussen

  188. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults

    Article • Growth Hormone & IGF Research, June 2004, Elsevier

    Professor Ulla Feldt-Rasmussen

  189. The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment

    Article • Growth Hormone & IGF Research, June 2004, Elsevier

    Professor Ulla Feldt-Rasmussen

  190. One‐year follow‐up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel®

    Article • Clinical Endocrinology, May 2004, Wiley

    Professor Ulla Feldt-Rasmussen

  191. Obesity: The New Worldwide Epidemic Threat to General Health and Our Complete Lack of Effective Treatment

    Article • Endocrinology, April 2004, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  192. Thyrotropin-Releasing Hormone Stimulation Test in Patients with Pituitary Pathology

    Article • Hormone Research in Paediatrics, January 2004, Karger Publishers

    Professor Ulla Feldt-Rasmussen

  193. Effect of Growth Hormone Replacement Therapy on Pituitary Hormone Secretion and Hormone Replacement Therapies in GHD Adults

    Article • Hormone Research in Paediatrics, January 2004, Karger Publishers

    Professor Ulla Feldt-Rasmussen

  194. Abnormal Sympathoadrenal Activity, but Normal Energy Expenditure in Hypopituitarism

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2003, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  195. High Risk of Adrenal Insufficiency in Adults Previously Treated for Idiopathic Childhood Onset Growth Hormone Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2003, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  196. Serum thyroglobulin as a marker of thyroid neoplasms after childhood cancer

    Article • Acta Paediatrica, November 2003, Wiley

    Professor Ulla Feldt-Rasmussen

  197. Circulating leptin and thyroid dysfunction

    Article • October 2003

    Professor Ulla Feldt-Rasmussen

  198. GHD during Critical Phases of Life

    Article • September 2003, Karger Publishers

    Professor Ulla Feldt-Rasmussen

  199. Assessment of the Hypothalamo-Pituitary-Adrenal Axis in Patients Treated with Radiotherapy and Chemotherapy for Childhood Brain Tumor

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2003, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  200. Ultrasonically measured horizontal eye muscle thickness in thyroid associated orbitopathy: cross-sectional and longitudinal aspects in a Danish series

    Article • Acta Ophthalmologica Scandinavica, April 2003, Wiley

    Professor Ulla Feldt-Rasmussen

  201. Reduced myo-inositol and total choline measured with cerebral MRS in acute thyrotoxic Graves’ disease

    Article • Neurology, January 2003, Wolters Kluwer Health

    Professor Ulla Feldt-Rasmussen

  202. Preface

    Article • Hormone Research in Paediatrics, January 2003, Karger Publishers

    Professor Ulla Feldt-Rasmussen

  203. A Population-Based Study of Thyroid Function after Radiotherapy and Chemotherapy for a Childhood Brain Tumor

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2003, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  204. Comparisons of leptin, incretins and body composition in obese and lean patients with hypopituitarism and healthy individuals

    Article • Clinical Endocrinology, January 2003, Wiley

    Professor Ulla Feldt-Rasmussen

  205. Immune function during GH treatment in GH‐deficient adults: an 18‐month randomized, placebo‐controlled, double‐blinded trial

    Article • Clinical Endocrinology, December 2002, Wiley

    Professor Ulla Feldt-Rasmussen

  206. Relationship between genotype and phenotype in 26 Danish patients with Fabry disease

    Article • Acta Paediatrica, November 2002, Wiley

    Professor Ulla Feldt-Rasmussen

  207. An audit of the insulin-tolerance test in 255 patients with pituitary disease

    Article • July 2002

    Professor Ulla Feldt-Rasmussen

  208. Fabry disease: a new challenge in endocrinology and metabolism?

    Article • June 2002

    Professor Ulla Feldt-Rasmussen

  209. Use of the 2nd generation TRAK human assay did not improve prediction of relapse after antithyroid medical therapy of Graves' disease

    Article • February 2002

    Professor Ulla Feldt-Rasmussen

  210. Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults--an 18-month randomised, placebo-controlled, double blinded trial

    Article • February 2002

    Professor Ulla Feldt-Rasmussen

  211. The influence of alpha1-acid glycoprotein (orosomucoid) and its glycoforms on the function of human thyrocytes and CHO cells transfected with the human TSH receptor

    Article • Molecular and Cellular Endocrinology, February 2002, Elsevier

    Professor Ulla Feldt-Rasmussen

  212. Cardiac Effects of Low-Dose Growth Hormone Replacement Therapy in Growth Hormone-Deficient Adults

    Article • Hormone Research in Paediatrics, January 2002, Karger Publishers

    Professor Ulla Feldt-Rasmussen

  213. Fabry Disease – A Metabolic Disorder with a Challenge for Endocrinologists?

    Article • Hormone Research in Paediatrics, January 2002, Karger Publishers

    Professor Ulla Feldt-Rasmussen

  214. Long-term Pathologic Changes of α 1 -Acid Glycoprotein (orosomucoid) Glycoforms in Autoimmune Thyroid Disease

    Article • Autoimmunity, January 2002, Taylor & Francis

    Professor Ulla Feldt-Rasmussen

  215. Increased risk of osteoporotic fractures in patients with Cushing's syndrome

    Article • January 2002

    Professor Ulla Feldt-Rasmussen

  216. Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease

    Article • January 2002

    Professor Ulla Feldt-Rasmussen

  217. Hydrogen peroxide-induced production of a 40 kDa immunoreactive thyroglobulin fragment in human thyroid cells: the onset of thyroid autoimmunity?

    Article • Biochemical Journal, December 2001, Portland Press Ltd.

    Professor Ulla Feldt-Rasmussen, Jean Ruf

  218. Total and free insulin-like growth factor I, insulin-like growth factor binding protein 3 and acid-labile subunit reflect clinical activity in acromegaly

    Article • Growth Hormone & IGF Research, December 2001, Elsevier

    Professor Ulla Feldt-Rasmussen

  219. Healthcare Consumption Decreases in Parallel with Improvements in Quality of Life during GH Replacement in Hypopituitary Adults with GH Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2001, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  220. Pregnancy Outcome in Type 1 Diabetic Women With Microalbuminuria

    Article • Diabetes Care, October 2001, American Diabetes Association

    Professor Ulla Feldt-Rasmussen

  221. Skin morphological changes in growth hormone deficiency and acromegaly

    Article • August 2001

    Professor Ulla Feldt-Rasmussen

  222. Thyroid function in survivors of childhood acute lymphoblastic leukaemia: the significance of prophylactic cranial irradiation

    Article • Clinical Endocrinology, July 2001, Wiley

    Professor Ulla Feldt-Rasmussen

  223. Iodine and Cancer

    Article • Thyroid, May 2001, Mary Ann Liebert Inc

    Professor Ulla Feldt-Rasmussen

  224. The Influence of Growth Hormone Deficiency, Growth Hormone Replacement Therapy, and Other Aspects of Hypopituitarism on Fracture Rate and Bone Mineral Density

    Article • Journal of Bone and Mineral Research, February 2001, Oxford University Press (OUP)

    Professor Ulla Feldt-Rasmussen

  225. How Should Insulin-Like Growth Factor I Be Measured?

    Article • Hormone Research in Paediatrics, January 2001, Karger Publishers

    Professor Ulla Feldt-Rasmussen

  226. Linomide Does Not Prevent Spontaneous Autoimmune Thyroiditis in NOD Mice

    Article • Autoimmunity, January 2001, Taylor & Francis

    Professor Ulla Feldt-Rasmussen

  227. Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2001, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  228. Sweat secretion rates in growth hormone disorders

    Article • Clinical Endocrinology, November 2000, Wiley

    Professor Ulla Feldt-Rasmussen

  229. Adrenaline and glycogenolysis in skeletal muscle during exercise: a study in adrenalectomised humans

    Article • The Journal of Physiology, October 2000, Wiley

    Professor Ulla Feldt-Rasmussen

  230. Growth hormone deficiency and replacement in elderly hypopituitary adults

    Article • Clinical Endocrinology, September 2000, Wiley

    Professor Ulla Feldt-Rasmussen

  231. Thyroperoxidase (TPO) immunostaining of the solitary cold thyroid nodule

    Article • Clinical Endocrinology, August 2000, Wiley

    Professor Ulla Feldt-Rasmussen

  232. (131)I and thyroid-associated ophthalmopathy

    Article • European Journal of Endocrinology, August 2000, Bioscientifica

    Professor Ulla Feldt-Rasmussen

  233. Cranial radiotherapy of childhood brain tumours: Growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study

    Article • Clinical Endocrinology, August 2000, Wiley

    Professor Ulla Feldt-Rasmussen

  234. Thyroperoxidase immunostaining in evaluation of thyroid nodules

    Article • Clinical Endocrinology, June 2000, Wiley

    Professor Ulla Feldt-Rasmussen

  235. Can growth hormone therapy cause diabetes?

    Article • The Lancet, May 2000, Elsevier

    Professor Ulla Feldt-Rasmussen

  236. Free and protein bound leptin are distinct and independently controlled factors in energy regulation

    Article • Diabetologia, April 2000, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  237. A Case of Sarcoidosis and Sarcoid Granuloma, Papillary Carcinoma, and Graves' Disease in the Thyroid Gland

    Article • Thyroid, March 2000, Mary Ann Liebert Inc

    Professor Ulla Feldt-Rasmussen

  238. Thyrocyte-interleukin-1 interactions

    Article • Experimental and Clinical Endocrinology & Diabetes, January 2000, Thieme Publishing Group

    Professor Ulla Feldt-Rasmussen

  239. Growth Hormone Response to a Growth Hormone-Releasing Hormone Stimulation Test in a Population-Based Study following Cranial Irradiation of Childhood Brain Tumors

    Article • Hormone Research in Paediatrics, January 2000, Karger Publishers

    Professor Ulla Feldt-Rasmussen

  240. Multicenter study on TGPO autoantibody prevalence in various thyroid and non-thyroid diseases; relationships with thyroglobulin and thyroperoxidase autoantibody parameters

    Article • December 1999

    Professor Ulla Feldt-Rasmussen, Jean Ruf

  241. The Effects of Treatment and the Individual Responsiveness to Growth Hormone (GH) Replacement Therapy in 665 GH-Deficient Adults

    Article • The Journal of Clinical Endocrinology & Metabolism, November 1999, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  242. Growth Hormone Replacement Therapy Is Not Associated with Any Increase in Mortality

    Article • The Journal of Clinical Endocrinology & Metabolism, November 1999, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  243. Effect of adrenaline on glucose kinetics during exercise in adrenalectomised humans

    Article • The Journal of Physiology, September 1999, Wiley

    Professor Ulla Feldt-Rasmussen

  244. ED4: QUALITY OF LIFE AND USE OF HEALTHCARE RESOURCES IN GROWTH HORMONE-DEFICIENT ADULTS AFTER GROWTH HORMONE REPLACEMENT THERAPY

    Article • Value in Health, September 1999, Elsevier

    Professor Ulla Feldt-Rasmussen

  245. Co-existence of osteogenesis imperfecta and hyperparathyroidism

    Article • Journal of Endocrinological Investigation, July 1999, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  246. Models to study the pathogenesis of thyroid autoimmunity

    Article • Biochimie, May 1999, Elsevier

    Professor Ulla Feldt-Rasmussen

  247. Lack of Thyroglobulin Production Supports the Finding of the FRTL-5 Cells with a Nondiploid Karyotype

    Article • Thyroid, May 1999, Mary Ann Liebert Inc

    Professor Ulla Feldt-Rasmussen

  248. Intestinal Adsorption of Levothyroxine by Antacids and Laxatives: Case Stories and in vitro Experiments

    Article • Pharmacology & Toxicology, March 1999, Wiley

    Professor Ulla Feldt-Rasmussen

  249. Thyrotropin Stimulates Specifically the Expression of the Autoantibody Binding Domains of the Thyroperoxidase Molecule

    Article • Autoimmunity, January 1999, Taylor & Francis

    Professor Ulla Feldt-Rasmussen

  250. Pathogenic and clinical aspects of Graves' disease

    Article • Experimental and Clinical Endocrinology & Diabetes, January 1999, Thieme Publishing Group

    Professor Ulla Feldt-Rasmussen

  251. The relationship between the serum leptin concentrations of thyrotoxic patients during treatment and their total fat mass is different from that of normal subjects

    Article • Clinical Endocrinology, November 1998, Wiley

    Professor Ulla Feldt-Rasmussen

  252. Efficacy of, and individual susceptibility to, GH-replacement in adults

    Article • Growth Hormone & IGF Research, August 1998, Elsevier

    Professor Ulla Feldt-Rasmussen

  253. Regrowth of non-secreting pituitary adenoma and craniopharyngioma prior to GH-replacement therapy in KIMS

    Article • Growth Hormone & IGF Research, August 1998, Elsevier

    Professor Ulla Feldt-Rasmussen

  254. Baseline characteristics and diagnosis of GHD in adults with hypopituitarism

    Article • Growth Hormone & IGF Research, August 1998, Elsevier

    Professor Ulla Feldt-Rasmussen

  255. Consequences of stopping growthhormone (GH) therapy in young GH deficient patients with childhood onset disease

    Article • Growth Hormone & IGF Research, February 1998, Elsevier

    Professor Ulla Feldt-Rasmussen

  256. Inhibition of PTH Secretion by Interleukin-1β in Bovine Parathyroid Glandsin VitroIs Associated with an Up-Regulation of the Calcium-Sensing Receptor mRNA

    Article • Biochemical and Biophysical Research Communications, September 1997, Elsevier

    Professor Ulla Feldt-Rasmussen

  257. The Effects of Interleukin-1β (IL-1β) on Human Thyrocyte Functions Are Counteracted by the IL-1 Receptor Antagonist1

    Article • Endocrinology, May 1997, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  258. Discrepancies between thyrotropin (TSH) measurement by four sensitive immunometric assays

    Article • Clinica Chimica Acta, March 1997, Elsevier

    Professor Ulla Feldt-Rasmussen

  259. Ectopic production of intact parathyroid hormone by a squamous cell lung carcinoma in vivo and in vitro.

    Article • The Journal of Clinical Endocrinology & Metabolism, October 1996, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  260. Interleukin-1  inhibits rat thyroid cell function in vivo and in vitro by an NO-independent mechanism and induces hypothyroidism and accelerated thyroiditis in diabetes-prone BB rats

    Article • October 1996, Bioscientifica

    Professor Ulla Feldt-Rasmussen

  261. A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells

    Article • Nephrology Dialysis Transplantation, September 1996, Oxford University Press (OUP)

    Professor Ulla Feldt-Rasmussen

  262. Long‐Term Observation of Serum Thyroglobulin after Resection of Nontoxic Goiter and Relation to Ultrasonographically Demonstrated Relapse

    Article • Extremophiles, March 1996, Wiley

    Professor Ulla Feldt-Rasmussen

  263. Thyroid function and autoimmunity in pernicious anemia before and during cyanocobalamin treatment

    Article • Journal of Endocrinological Investigation, February 1995, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  264. Diagnosis and treatment of thyrotoxicosis in childhood A European questionnaire study

    Article • November 1994

    Professor Ulla Feldt-Rasmussen

  265. Bispecific thyroglobulin and thyroperoxidase autoantibodies in patients with various thyroid and autoimmune diseases.

    Article • The Journal of Clinical Endocrinology & Metabolism, November 1994, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  266. Influence of tumour necrosis factor- , tumour necrosis factor-  and interferon- , separately and added together with interleukin-1  , on the function of cultured human thyroid cells

    Article • November 1994, Bioscientifica

    Professor Ulla Feldt-Rasmussen

  267. Riedel's thyroiditis: an autoimmune or primary fibrotic disease?

    Article • Journal of Internal Medicine, March 1994, Wiley

    Professor Ulla Feldt-Rasmussen

  268. Nitric Oxide Production is not involved in the Effects of Interleukin-1β on CAMP, Thyroglobulin and Interleukin-6 in TSH-Stimulated Human Thyroid Cells

    Article • Autoimmunity, January 1994, Taylor & Francis

    Professor Ulla Feldt-Rasmussen

  269. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease

    Article • The Journal of Clinical Endocrinology & Metabolism, January 1994, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  270. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease.

    Article • The Journal of Clinical Endocrinology & Metabolism, January 1994, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  271. Reassessment of Antithyroid Drug Therapy of Graves' Disease

    Article • Annual Review of Medicine, February 1993, Annual Reviews

    Professor Ulla Feldt-Rasmussen

  272. Reassessment of Antithyroid Drug Therapy of Graves' Disease

    Article • Annual Review of Medicine, January 1993, Annual Reviews

    Professor Ulla Feldt-Rasmussen

  273. Update: The Effect of Interleukin-1 on the Thyroid Gland

    Article • Autoimmunity, January 1993, Taylor & Francis

    Professor Ulla Feldt-Rasmussen

  274. Postpartum Thyroid Dysfunction: Comment

    Article • Thyroid, January 1992, Mary Ann Liebert Inc

    Professor Ulla Feldt-Rasmussen

  275. Influence of thyroxine treatment on thyroid size and anti-thyroid peroxidase antibodies in Hashimoto's thyroiditis

    Article • Clinical Endocrinology, September 1991, Wiley

    Professor Ulla Feldt-Rasmussen

  276. Effect of maternal thyroid autoantibodies and post-partum thyroiditis on the fetus and neonate

    Article • August 1991

    Professor Ulla Feldt-Rasmussen

  277. Evidence for acute release of thyroid peroxidase during subtotal thyroidectomy

    Article • June 1991

    Professor Ulla Feldt-Rasmussen

  278. Influence of interleukin 6 on the function of secondary cultures of human thyrocytes

    Article • May 1991

    Professor Ulla Feldt-Rasmussen

  279. Thyroid function and autoimmune manifestations in insulin-dependent diabetes mellitus during and after pregnancy

    Article • May 1991

    Professor Ulla Feldt-Rasmussen

  280. Thyroid function tests in patients with acquired immune deficiency syndrome and healthy HIV1‐positive out‐patients

    Article • European Journal of Clinical Investigation, February 1991, Wiley

    Professor Ulla Feldt-Rasmussen

  281. Interleukin-6 Is Not a Second Mediator of Interleukin-1 Induced Suppression of Thyroid Function in Cultured Human Thyrocytes

    Article • Experimental and Clinical Endocrinology & Diabetes, January 1991, Thieme Publishing Group

    Professor Ulla Feldt-Rasmussen

  282. Interleukin 6: A Pathogenic Factor in Autoimmune Thyroid Diseases?

    Article • January 1991, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  283. Thyroid Peroxidase and Thyroid Autoimmunity Report on the International Symposium on Thyroperoxidase and Thyroid Autoimmunity, held in Marseille (France), June 28–30, 1990

    Article • Autoimmunity, January 1991, Taylor & Francis

    Professor Ulla Feldt-Rasmussen

  284. Comparison Between Microsomal Antibodies by Immunofluorescence and Anti-TPO Antibodies in Healthy Individuals and Thyroid Autoimmune Diseases

    Article • January 1991, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  285. Endotoxins Do not Mimick the Effect of Interleukin-1 in Secondary Cultures of Human Thyroid Cells

    Article • January 1991, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  286. The Thyroid Function and Size in Healthy Man During 3 Weeks Treatment with β-Adrenoceptor-Antagonists

    Article • Hormone and Metabolic Research, January 1991, Thieme Publishing Group

    Professor Ulla Feldt-Rasmussen

  287. Anti-Thyroid Peroxidase Antibodies in Thyroid Disorders and Non-Thyroid Autoimmune Diseases

    Article • Autoimmunity, January 1991, Taylor & Francis

    Professor Ulla Feldt-Rasmussen

  288. Thyroid size and function in healthy pregnant women with thyroid autoantibodies. Relation to development of postpartum thyroiditis

    Article • October 1990

    Professor Ulla Feldt-Rasmussen

  289. Differential effects of interleukin 1  and 1  on cultured human and rat thyroid epithelial cells

    Article • April 1990

    Professor Ulla Feldt-Rasmussen

  290. Anti-Thyroid Peroxidase Antibodies During Pregnancy and Postpartum. Relation to Postpartum Thyroiditis

    Article • Autoimmunity, January 1990, Taylor & Francis

    Professor Ulla Feldt-Rasmussen

  291. The variable intrafamiliar expressivity in Pendred's syndrome

    Article • Clinical Otolaryngology, October 1989, Wiley

    Professor Ulla Feldt-Rasmussen

  292. Characterization of the natural killer cell activity in Hashimoto's and Graves' diseases

    Article • Allergy, October 1989, Wiley

    Professor Ulla Feldt-Rasmussen

  293. Serum thyroglobulin during the menstrual cycle, during pregnancy, and post partum

    Article • August 1989

    Professor Ulla Feldt-Rasmussen

  294. FEATURES OF ENDOTHELIAL DYSFUNCTION IN EARLY DIABETIC NEPHROPATHY

    Article • The Lancet, March 1989, Elsevier

    Professor Ulla Feldt-Rasmussen

  295. Suppressed Natural Killer Cell Activity in Patients with Euthyroid Graves' Ophthalmopathy

    Article • Autoimmunity, January 1989, Taylor & Francis

    Professor Ulla Feldt-Rasmussen

  296. Interleukin‐1 affects the function of cultured human thyroid cells

    Article • Allergy, August 1988, Wiley

    Professor Ulla Feldt-Rasmussen

  297. Pathogenic role of interleukin 1 and tumor necrosis factor in autoimmune endocrine diseases

    Article • Clinical Immunology Newsletter, May 1988, Elsevier

    Professor Ulla Feldt-Rasmussen

  298. Lacking evidence for release of thyroid hormones from circulating thyroglobulin during subtotal thyroidectomy

    Article • February 1988

    Professor Ulla Feldt-Rasmussen

  299. Thyroid function in patients with Pendred’s syndrome

    Article • Journal of Endocrinological Investigation, February 1988, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  300. Thyroid stimulating antibodies in rheumatoid arthritis: an in vitro phenomenon

    Article • Journal of Endocrinological Investigation, October 1987, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  301. The influence of interleukin-1 on the function of in vitro cultured human thyroid cells in monolayers

    Article • August 1987

    Professor Ulla Feldt-Rasmussen

  302. Increased sympathetic tone in forearm subcutaneous tissue in primary hypothyroidism

    Article • Clinical Physiology and Functional Imaging, August 1987, Wiley

    Professor Ulla Feldt-Rasmussen

  303. Thyroid function in patients with breast cancer

    Article • European Journal of Cancer and Clinical Oncology, May 1987, Elsevier

    Professor Ulla Feldt-Rasmussen

  304. IgG SUBCLASS DISTRIBUTION OF THYROID AUTOANTIBODIES: A ‘FINGERPRINT’ OF AN INDIVIDUAL'S RESPONSE TO THYROGLOBULIN AND THYROID MICROSOMAL ANTIGEN

    Article • Clinical Endocrinology, March 1987, Wiley

    Professor Ulla Feldt-Rasmussen

  305. Cytokines in autoimmunity

    Article • Immunology Today, January 1987, Elsevier

    Professor Ulla Feldt-Rasmussen

  306. Serum thyroglobulin in chronic renal failure—effects of haemodialysis

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 1987, Taylor & Francis

    Professor Ulla Feldt-Rasmussen

  307. Natural Killer Cell Activity in Hashimoto, Graves’ Disease and Euthyroid Exophthalmos

    Article • January 1987, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  308. Serum thyroglobulin in chronic renal failure—effects of haemodialysis

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 1987, Taylor & Francis

    Professor Ulla Feldt-Rasmussen

  309. Serum Thyroid Autoantibodies in Patients with Breast Cancer

    Article • January 1987, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  310. Thyroid Autoantibodies in Thyroid Cancer

    Article • January 1987, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  311. Persistence of Autoimmune Reactions During Recovery of Subacute Thyroiditis

    Article • January 1987, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  312. The Influence of Interleukin-1 on The Function of Human Thyroid Cells

    Article • January 1987, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  313. Thyroid Stimulating Immunoglobulins without Evidence of in Vivo Thyroid Stimulation in Some Non-Thyroid Autoimmune Diseases

    Article • January 1987, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  314. COMPARISON BETWEEN HOMOGENEOUS PHASE RADIO‐ASSAY AND ENZYME‐LINKED IMMUNOSORBENT ASSAY FOR MEASUREMENT OF ANTITHYROGLOBULIN ANTIBODY CONTENT IN SERUM

    Article • Acta Pathologica Microbiologica Scandinavica Series C Immunology, November 1986, Wiley

    Professor Ulla Feldt-Rasmussen

  315. AUTOREACTIVE LYMPHOCYTES IN THYROID DISORDERS

    Article • Acta Pathologica Microbiologica Scandinavica Series C Immunology, November 1986, Wiley

    Professor Ulla Feldt-Rasmussen

  316. SERUM THYROGLOBULIN CONCENTRATIONS IN INFANTS OF VARIOUS MATURITY

    Article • Pediatric Research, November 1986, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  317. Short-term betaadrenergic blockade decreases serum thyroglobulin in hyper- and euthyroid patients

    Article • Journal of Endocrinological Investigation, October 1986, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  318. Autoreactive lymphocytes in thyroid disorders. Quantitation of anti-thyroglobulin antibody formation by a specific haemolytic plaque forming cell (PFC) assay

    Article • September 1986

    Professor Ulla Feldt-Rasmussen

  319. Serum thyroglobulin concentration in nontoxic goiter and response to surgery with special reference to risk of goiter relapse

    Article • Extremophiles, August 1986, Wiley

    Professor Ulla Feldt-Rasmussen

  320. Serum thyroglobulin (Tg) in presence of thyroglobulin autoantibodies (TgAb). Clinical and methodological relevance of the interaction between Tg and TgAb in vitro and in vivo

    Article • Journal of Endocrinological Investigation, December 1985, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  321. Kinetic Models for Plasma Disappearance of Insulin in Normal Subjects

    Article • Acta Pharmacologica et Toxicologica, November 1985, Wiley

    Professor Ulla Feldt-Rasmussen

  322. Humoral Autoimmune Manifestation in Subacute Thyroiditis

    Article • Allergy, November 1985, Wiley

    Professor Ulla Feldt-Rasmussen

  323. INCREASED FREQUENCY OF GOITRE IN EPILEPTIC PATIENTS ON LONG‐TERM PHENYTOIN OR CARBAMAZEPINE TREATMENT

    Article • Clinical Endocrinology, October 1985, Wiley

    Professor Ulla Feldt-Rasmussen

  324. HIGH FREQUENCY OF GOITRE IN CIGARETTE SMOKERS

    Article • Clinical Endocrinology, March 1985, Wiley

    Professor Ulla Feldt-Rasmussen

  325. An enzyme linked immunosorbent assay (ELISA) for measurement of human serum thyroglobulin. Evaluation of the influence of thyroglobulin auto-antibodies

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 1985, Taylor & Francis

    Professor Ulla Feldt-Rasmussen

  326. The differential diagnostic problems in unilateral euthyroid Graves' ophthalmopathy

    Article • August 1984

    Professor Ulla Feldt-Rasmussen

  327. Heterogeneity of Autoimmune Thyroiditis

    Article • Allergy, May 1984, Wiley

    Professor Ulla Feldt-Rasmussen

  328. Relationship between thyroid volume and serum thyroglobulin during long-term suppression with triiodothyronine in patients with diffuse non-toxic goitre

    Article • February 1984

    Professor Ulla Feldt-Rasmussen

  329. Autoantibodies, immune complexes and HLA‐D in thyrogastric autoimmunity

    Article • Tissue Antigens, November 1983, Wiley

    Professor Ulla Feldt-Rasmussen

  330. Serum Thyroglobulin and Thyroglobulin Autoantibodies in Thyroid Diseases

    Article • Allergy, August 1983, Wiley

    Professor Ulla Feldt-Rasmussen

  331. SERUM THYROGLOBULIN IN ACUTE AND CHRONIC LIVER DISEASE

    Article • Clinical Endocrinology, August 1983, Wiley

    Professor Ulla Feldt-Rasmussen

  332. Circulating Immune Complexes in Hashimoto's Thyroiditis

    Article • Allergy, August 1983, Wiley

    Professor Ulla Feldt-Rasmussen

  333. HLA‐D in Hashimoto's thyroiditis

    Article • Tissue Antigens, February 1983, Wiley

    Professor Ulla Feldt-Rasmussen

  334. Discrepancy between Haemagglutination and Radioimmunological Techniques for Measurement of Serum Thyroglobulin Autoantibodies

    Article • Allergy, January 1983, Wiley

    Professor Ulla Feldt-Rasmussen

  335. Thyroid-Stimulating Immunoglobulins in Hashimoto′s Thyroiditis Measured byRadioreceptor Assay and Adenylate Cyclase Stimulation and Their Relationship to HLA-D Alleles*

    Article • The Journal of Clinical Endocrinology & Metabolism, November 1982, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  336. Serum thyroglobulin and its autoantibody following subtotal thyroid resection of Graves' disease

    Article • European Journal of Clinical Investigation, June 1982, Wiley

    Professor Ulla Feldt-Rasmussen

  337. Serum thyroglobulin in patients undergoing subtotal thyroidectomy for toxic and nontoxic goiter

    Article • Journal of Endocrinological Investigation, May 1982, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen

  338. Thyroid Stimulating Antibodies, Thyroglobulin Antibodies and Serum Proteins during Treatment of Graves’ Disease with Radioiodine or Propylthouracil

    Article • Allergy, April 1982, Wiley

    Professor Ulla Feldt-Rasmussen

  339. THE ACUTE CHANGES IN THYROID STIMULATING IMMUNOGLOBULINS, THYROGLOBULIN AND THYROGLOBULIN ANTIBODIES FOLLOWING SUBTOTAL THYROIDECTOMY*

    Article • Clinical Endocrinology, March 1982, Wiley

    Professor Ulla Feldt-Rasmussen

  340. A prospective study of the differential changes in serum thyroglobulin and its autoantibodies during propylthiouracil or radioiodine therapy of patients with Graves' disease

    Article • March 1982

    Professor Ulla Feldt-Rasmussen

  341. Influence of Thyroglobulin on Basal and Stimulated Human Thyroid Adenylate Cyclase Activity*

    Article • The Journal of Clinical Endocrinology & Metabolism, August 1981, Endocrine Society

    Professor Ulla Feldt-Rasmussen

  342. In vitro Characterization of Synthesized Thyroglobulin Immune Complexes (IC)

    Article • Allergy, February 1981, Wiley

    Professor Ulla Feldt-Rasmussen

  343. Propranolol in the Treatment of Thyrotoxicosis

    Article • Acta Medica Scandinavica, January 1981, Wiley

    Professor Ulla Feldt-Rasmussen

  344. Variability of plasma proteins according to molecular size. Long-term and short-term intra-individual variation

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 1981, Taylor & Francis

    Professor Ulla Feldt-Rasmussen

  345. Long-term variability in serum thyroglobulin and thyroid related hormones in healthy subjects

    Article • November 1980

    Professor Ulla Feldt-Rasmussen

  346. Circulating Immune Complexes and Complement-fixing Antibodies in Patients with Varicella-Zoster Infection: Relationship to Début of the Disease

    Article • Scandinavian Journal of Infectious Diseases, March 1980, Taylor & Francis

    Professor Ulla Feldt-Rasmussen

  347. SEQUENTIAL CHANGES IN SERUM THYROGLOBULIN (Tg) AND ITS AUTOANTIBODIES (TgAb) FOLLOWING SUBTOTAL THYROIDECTOMY OF PATIENTS WITH PREOPERATIVELY DETECTABLE TgAb

    Article • Clinical Endocrinology, January 1980, Wiley

    Professor Ulla Feldt-Rasmussen

  348. Falsely negative urinary leucocyte counts due to delayed examination

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 1980, Taylor & Francis

    Professor Ulla Feldt-Rasmussen

  349. Variations in Plasma Protein Concentrations in Individuals with Ulcerative Colitis: Analytical and Biological Factors

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, October 1979, Taylor & Francis

    Professor Ulla Feldt-Rasmussen

  350. SERUM THYROGLOBULIN IN PATIENTS WITH TOXIC AND NON-TOXIC GOITRES COMPARED TO SEX- AND AGE-MATCHED CONTROL SUBJECTS

    Article • June 1979

    Professor Ulla Feldt-Rasmussen

  351. SEX AND AGE CORRELATED REFERENCE VALUES OF SERUM THYROGLOBULIN MEASURED BY A MODIFIED RADIOIMMUNOASSAY

    Article • March 1979

    Professor Ulla Feldt-Rasmussen

  352. EFFECT OF CLOMIFENE ON THYROID FUNCTION IN NORMAL MEN

    Article • January 1979

    Professor Ulla Feldt-Rasmussen

  353. THYROGLOBULIN OF VARYING MOLECULAR SIZES WITH DIFFERENT DISAPPEARANCE RATES IN PLASMA FOLLOWING SUBTOTAL THYROIDECTOMY

    Article • Clinical Endocrinology, September 1978, Wiley

    Professor Ulla Feldt-Rasmussen

  354. Purification of human thyroglobulin for radioimmunoassay and testing by ultracentrifugal analysis and immunoelectrophoresis

    Article • Journal of Immunological Methods, June 1978, Elsevier

    Professor Ulla Feldt-Rasmussen

  355. ADDITION OF MECHANICAL DEAD SPACE DURING I.P.P.B. WITH THE PREDICTED VITAL CAPACITY AS THE GUIDE

    Article • Acta Anaesthesiologica Scandinavica, March 1970, Wiley

    Professor Ulla Feldt-Rasmussen

  356. Infusion Urography

    Article • Acta Radiologica, January 1967, SAGE Publications

    Professor Ulla Feldt-Rasmussen

  357. Infusion Urography

    Article • Acta Radiologica, January 1967, SAGE Publications

    Professor Ulla Feldt-Rasmussen